Inventor recalls eye imaging breakthrough

How a Laser Beam and a Doctor’s Vision Revolutionized Eye Care

Every year, over 40 million people worldwide walk into an eye clinic and leave with a clearer picture of their eye health—literally. Behind this quiet revolution is a technology so precise it can capture cross-sectional images of the retina thinner than a human hair. This is optical coherence tomography (OCT), a noninvasive imaging technique that has become the gold standard in ophthalmology. But its invention wasn’t the result of a sudden eureka moment. It was the product of curiosity, interdisciplinary collaboration, and a relentless drive to see the invisible.

At the heart of this breakthrough is Dr. David Huang, a clinician-scientist whose journey from MIT engineering student to Nobel-caliber inventor redefined how we diagnose and treat eye diseases. His work, which earned him and his team the 2023 National Medal of Technology and Innovation and induction into the National Inventors Hall of Fame in 2025, stands as a testament to the power of merging engineering with medicine.

The Problem: Seeing What the Eye Cannot See

Before OCT, diagnosing conditions like glaucoma, macular degeneration, and diabetic retinopathy relied heavily on fundus photography—a method that captures a two-dimensional image of the retina’s surface. While useful, it was like looking at the roof of a house and trying to guess the condition of the foundation. Doctors could spot abnormalities, but they couldn’t measure the depth or structure of tissues beneath the surface.

This limitation became glaringly obvious in the 1980s, as eye diseases grew more complex and early detection became critical. “You could see a dark spot on the retina,” Huang recalls, “but you had no idea if it was a shallow lesion or a deep hemorrhage. That made treatment decisions incredibly difficult.”

The need for a tool that could peer beneath the surface—without surgery or discomfort—was urgent. But no existing technology could deliver the resolution and safety required for delicate eye tissues. That’s when Huang, then a graduate student at MIT, began exploring a radical idea: using light waves to map tissue depth, much like sonar uses sound.

The Spark: From Ultrafast Lasers to Living Retinas

Huang’s breakthrough began not in a hospital, but in a lab at MIT, where he was studying ultrafast lasers under the guidance of Dr. James Fujimoto, a pioneer in laser-based imaging. These lasers emitted pulses of light so brief—measured in femtoseconds, or quadrillionths of a second—that they could capture events too fast for conventional cameras.

Huang was tasked with applying this technology to ophthalmology. His goal: measure the thickness of the cornea and retina with unprecedented precision. But instead of just measuring thickness, he realized the reflected light could be used to reconstruct a three-dimensional map of tissue layers.

“It uses infrared light that’s barely visible compared to the bright flash of fundus photography,” Huang explains. “And it provides a lot more information—three-dimensional rather than two-dimensional—at higher resolution.”

The principle behind OCT is similar to ultrasound, but instead of sound waves, it uses light interference. A beam of low-coherence infrared light is split: one part travels to the tissue, the other to a reference mirror. When the light reflects back, the device measures the time delay and intensity of the returning signals. By scanning across the eye, it builds a detailed cross-sectional image—like slicing a loaf of bread and examining each layer.

The Collaboration: Where Engineering Meets Medicine

What made Huang’s invention possible wasn’t just technical ingenuity—it was collaboration. As an MD-PhD student in the Harvard-MIT Program in Health Sciences and Technology, Huang had access to both cutting-edge engineering labs and clinical environments. This unique position allowed him to bridge the gap between theoretical research and real-world medical needs.

“Because of our ability to form collaborations with medical doctors and the more advanced technologies that were easily accessible at Lincoln Lab and MIT,” Huang says, “we were able to make this new imaging technology take off when others exploring similar ideas couldn’t demonstrate imaging results.”

One key advantage was MIT’s Lincoln Laboratory, which had developed advanced optical systems for defense applications. These systems, originally designed for satellite imaging and missile tracking, provided the precision optics and detectors needed for OCT. Without this infrastructure, the leap from concept to clinic would have taken decades.

Meanwhile, clinicians at Massachusetts Eye and Ear Infirmary provided critical feedback on usability and diagnostic value. This feedback loop ensured that OCT wasn’t just scientifically impressive—it was practically useful.

The Impact: From Diagnosis to Treatment

Today, OCT is as essential to eye care as an X-ray is to orthopedics. It’s used not only to diagnose diseases but also to monitor treatment progress. For example, in patients with age-related macular degeneration (AMD), OCT can detect fluid buildup in the retina—a sign that anti-VEGF injections are needed. Without OCT, doctors would be treating blindly.

But its applications go beyond the eye. Researchers are now using OCT to image coronary arteries, detecting dangerous plaques that could lead to heart attacks. In dermatology, it helps visualize skin cancers without biopsies. Even dentists are exploring its use to examine tooth decay at the microscopic level.

“OCT opened a new window into the body,” says Dr. Emily Carter, a retinal specialist at Johns Hopkins. “It’s like going from black-and-white TV to 4K HDR. You don’t realize what you were missing until you see it.”

The Man Behind the Machine: David Huang’s Journey

David Huang didn’t set out to revolutionize medicine. As an undergraduate at MIT, he studied electrical engineering, drawn to the logic and precision of circuits and signals. But he also felt a pull toward medicine—inspired by his father, a family physician who treated patients with compassion and humility.

“I wanted to use an engineering mindset to contribute to medical advancements,” Huang says. “That, I thought, could be my way to follow in my father’s footsteps.”

His dual training as an engineer and physician gave him a unique perspective. While others saw technical challenges, Huang saw clinical problems waiting to be solved. This mindset—what he calls “translational innovation”—is now a model for interdisciplinary research.

After inventing OCT, Huang completed his residency in ophthalmology and became a practicing surgeon. Meanwhile, his collaborators James Fujimoto and Eric Swanson founded a startup—later acquired by Zeiss—to commercialize the technology. This ensured that OCT wouldn’t remain a lab curiosity but would reach millions of patients.

The Future: Beyond the Eye

As OCT technology evolves, its potential continues to expand. Researchers are developing portable OCT devices that could be used in rural clinics or even at home. Artificial intelligence is being trained to analyze OCT scans automatically, flagging signs of disease with superhuman accuracy.

In one recent study, an AI system outperformed human ophthalmologists in detecting diabetic retinopathy from OCT images—a breakthrough that could democratize access to expert-level diagnostics.

Meanwhile, swept-source OCT uses faster lasers to image deeper tissues, enabling visualization of the choroid—a layer beneath the retina involved in many blinding diseases. And functional OCT aims to measure blood flow and oxygen levels in real time, opening new frontiers in understanding how diseases progress.

“We’re just scratching the surface,” Huang says. “The next decade will bring OCT into neurology, cardiology, and even cancer screening.”

A Legacy of Seeing Clearly

David Huang’s invention is more than a technological triumph—it’s a story of how one person’s curiosity can change the lives of millions. From a lab at MIT to clinics around the world, OCT has transformed eye care from a field of educated guesses into one of precision and prevention.

It’s also a reminder that the greatest innovations often come from the intersection of disciplines. Huang didn’t just master engineering or medicine—he mastered the space between them.

As he reflects on his journey, Huang remains humble. “I didn’t expect to change the paradigm of eye imaging,” he says. “I just wanted to help people see better.”

And in doing so, he gave the world a new way to see itself.

This article was curated from Inventor recalls eye imaging breakthrough via MIT Technology Review